Clinical Trial Update: Alternating Cycles of Carboplatin/Gemcitabine and Carboplatin/Taxol for Advanced Stage NSCLC [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluating alternating cycles of carboplatin/gemcitabine and carboplatin/paclitaxel for advanced non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Gemzar (gemcitabine)
• Paraplatin (Carboplatin)
• Taxol (paclitaxel)

Snippet

Sponsor: University of Saskatchewan | Conditions: Non Small Cell Lung Cancer | Phase 2 | Status: COMPLETED